980 related articles for article (PubMed ID: 29248163)
21. Rationale and design of AXAFA-AFNET 5: an investigator-initiated, randomized, open, blinded outcome assessment, multi-centre trial to comparing continuous apixaban to vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation.
Di Biase L; Callans D; Hæusler KG; Hindricks G; Al-Khalidi H; Mont L; Cosedis Nielsen J; Piccini JP; Schotten U; Kirchhof P
Europace; 2017 Jan; 19(1):132-138. PubMed ID: 28130378
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
[No Abstract] [Full Text] [Related]
23. Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial Fibrillation.
Patti G; Pecen L; Lucerna M; Huber K; Rohla M; Renda G; Siller-Matula J; Ricci F; Kirchhof P; De Caterina R
Am J Med; 2019 Jun; 132(6):749-757.e5. PubMed ID: 30664837
[TBL] [Abstract][Full Text] [Related]
24. Non-Vitamin K Antagonist Oral Anticoagulants in Asian Patients With Supranormal Renal Function.
Lee SR; Choi EK; Han KD; Jung JH; Cha MJ; Oh S; Lip GYH
Stroke; 2019 Jun; 50(6):1480-1489. PubMed ID: 31084339
[TBL] [Abstract][Full Text] [Related]
25. Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation.
Senoo K; Lip GY
Semin Thromb Hemost; 2015 Mar; 41(2):146-53. PubMed ID: 25682085
[TBL] [Abstract][Full Text] [Related]
26. Non-vitamin K antagonist oral anticoagulants in atrial fibrillation accompanying mitral stenosis: the concept for a trial.
De Caterina R; John Camm A
Europace; 2016 Jan; 18(1):6-11. PubMed ID: 26450845
[TBL] [Abstract][Full Text] [Related]
27. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
Potpara TS; Lip GY
Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
[TBL] [Abstract][Full Text] [Related]
28. Treatment Changes among Users of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation.
Hellfritzsch M; Husted SE; Grove EL; Rasmussen L; Poulsen BK; Johnsen SP; Hallas J; Pottegård A
Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):187-194. PubMed ID: 27580086
[TBL] [Abstract][Full Text] [Related]
29. Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation.
Vedovati MC; Verdecchia P; Giustozzi M; Molini G; Conti S; Pierpaoli L; Valecchi F; Aita A; Agnelli G; Becattini C
Int J Cardiol; 2017 Jun; 236():363-369. PubMed ID: 28131705
[TBL] [Abstract][Full Text] [Related]
30. Challenges in comparing the non-vitamin K antagonist oral anticoagulants for atrial fibrillation-related stroke prevention.
Camm AJ; Fox KAA; Peterson E
Europace; 2018 Jan; 20(1):1-11. PubMed ID: 29040518
[TBL] [Abstract][Full Text] [Related]
31. Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation.
Bisson A; Angoulvant D; Philippart R; Clementy N; Babuty D; Fauchier L
Adv Ther; 2017 Jun; 34(6):1283-1290. PubMed ID: 28493056
[TBL] [Abstract][Full Text] [Related]
32. Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis.
Caldeira D; David C; Costa J; Ferreira JJ; Pinto FJ
Eur Heart J Cardiovasc Pharmacother; 2018 Apr; 4(2):111-118. PubMed ID: 28950374
[TBL] [Abstract][Full Text] [Related]
33. Adequacy of preadmission oral anticoagulation with vitamin K antagonists and ischemic stroke severity and outcome in patients with atrial fibrillation.
Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Dourliou V; Sofogianni A; Savopoulos C; Hatzitolios AI
J Thromb Thrombolysis; 2016 Feb; 41(2):336-42. PubMed ID: 26253707
[TBL] [Abstract][Full Text] [Related]
34. The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated?
Hammwöhner M; Goette A
J Cardiovasc Pharmacol; 2015 Dec; 66(6):530-9. PubMed ID: 26222990
[TBL] [Abstract][Full Text] [Related]
35. Dosing issues with non-vitamin K antagonist oral anticoagulants for the treatment of non-valvular atrial fibrillation: Why we should not underdose our patients.
Dillinger JG; Aleil B; Cheggour S; Benhamou Y; Béjot Y; Marechaux S; Delluc A; Bertoletti L; Lellouche N
Arch Cardiovasc Dis; 2018 Feb; 111(2):85-94. PubMed ID: 28988597
[TBL] [Abstract][Full Text] [Related]
36. Non-vitamin K oral anticoagulants in nonvalvular atrial fibrillation: a network meta-analysis.
Antza C; Doundoulakis I; Akrivos E; Economou F; Vazakidis P; Haidich AB; Kotsis V
Scand Cardiovasc J; 2019 Apr; 53(2):48-54. PubMed ID: 30896311
[TBL] [Abstract][Full Text] [Related]
37. Effectiveness and Safety of Non-Vitamin K Oral Anticoagulants in Comparison to Phenprocoumon: Data from 61,000 Patients with Atrial Fibrillation.
Hohnloser SH; Basic E; Hohmann C; Nabauer M
Thromb Haemost; 2018 Mar; 118(3):526-538. PubMed ID: 29359278
[TBL] [Abstract][Full Text] [Related]
38. Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials.
Patti G; Di Gioia G; Cavallari I; Nenna A
Diabetes Metab Res Rev; 2017 Mar; 33(3):. PubMed ID: 28029216
[TBL] [Abstract][Full Text] [Related]
39. Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study.
Bouillon K; Bertrand M; Maura G; Blotière PO; Ricordeau P; Zureik M
Lancet Haematol; 2015 Apr; 2(4):e150-9. PubMed ID: 26687957
[TBL] [Abstract][Full Text] [Related]
40. Cardioversion of atrial fibrillation in a real-world setting: non-vitamin K antagonist oral anticoagulants ensure a fast and safe strategy compared to warfarin.
Frederiksen AS; Albertsen AE; Christesen AMS; Vinter N; Frost L; Møller DS
Europace; 2018 Jul; 20(7):1078-1085. PubMed ID: 28655151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
